[Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study].
Naumann
M
M
Medizinische Klinik II, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt.
Schaum
B
B
Oremek
G M
GM
Hanisch
E
E
Rösch
W
W
Mössner
J
J
Caspary
W F
WF
Stein
J
J
D000236:Adenoma / Q000175:diagnosis / Q000201:enzymology; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000201:enzymology; D003111:Colonic Polyps / Q000175:diagnosis / Q000201:enzymology; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000201:enzymology; D003424:Crohn Disease / Q000175:diagnosis / Q000201:enzymology; D003937:Diagnosis, Differential; D004403:Dysentery / Q000175:diagnosis / Q000201:enzymology; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces / Q000201:enzymology*; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods* / Q000592:standards; D009780:Occult Blood; D011770:Pyruvate Kinase / Q000032:analysis*; D012680:Sensitivity and Specificity
D011770:Pyruvate Kinase